Dr Reddy's in collaboration with SkyePharma on delivery system

-

Dr Reddy's in collaboration with SkyePharma on delivery system


Using two of SkyePharma's unique drug delivery systems, the UK company SkyePharma has agreed to conduct a feasibility study on an unnamed product with Dr Reddy's Laboratories of India.


The study's expenses will be covered by Dr. Reddy's, and SkyePharma will also get a "small" up-front payment, according to the two businesses. Full development activities would start later this year, they stated, if the feasibility study is successful. 


With organizations like GlaxoSmithKline, Roche, Schiele, Novartis, AstraZeneca, Nitec, and Abbott in the past, SkyePharma has collaborated on the development of both licensed pharmaceuticals as well as drugs in development that use the oral, inhalation, and topical drug delivery technologies of the UK company. 


The FDA recently requested a second clinical study to gather additional efficacy data on the bronchodilator/steroid combination found in SkyePharma's proprietary non-CFC metered-dose aerosol inhaler, which resulted in the announcement that the planned new drug application (NDA) for Flutiform in the US would be delayed.

Comments

Post a Comment

Popular posts from this blog

 Role of Blockchain in Healthcare Data Management

-
Image
ROLE OF BLOCKCHAIN IN HEALTHCARE DATA MANAGEMENT I n recent years, the healthcare industry has been undergoing a digital transformation, leveraging innovative technologies to improve patient care and data management.   One such technology that has gained significant attention is blockchain. Originally known for powering cryptocurrencies like Bitcoin, blockchain has found a remarkable application in healthcare data management.  This decentralized and secure ledger system holds immense potential to revolutionize the way sensitive medical information is stored, shared, and utilized across the healthcare ecosystem.  What is  Role of Blockchain in Healthcare Data Management? Blockchain technology has the potential to  revolutionize healthcare data management. It is a type of distributed ledger technology (DLT)  that leverages decentralized peer-to-peer computing, cryptography, and related technology to verify and propagate a chain of transaction records across a consortium, alliance, part
Read more

Demystifying AI in Drug Discovery: Transforming Pharma R&D

-
Image
Demystifying AI in Drug Discovery: Transforming Pharma R&D Artificial Intelligence (AI) has swiftly transformed industries, and drug discovery is no exception.  The pharmaceutical research and development (R&D) process has traditionally been lengthy, resource-intensive, and marked by high failure rates. However, with the advent of AI, a new era has dawned, promising to revolutionize the drug discovery landscape.  This article delves into the nuances of AI in drug discovery , exploring how it's reshaping pharma R&D processes and accelerating the journey toward innovative therapies. 1. Understanding AI in Drug Discovery: AI refers to the simulation of human intelligence in machines, enabling them to perform tasks that typically require human cognition, such as learning, reasoning, and problem-solving.  In drug discovery, AI algorithms analyze vast datasets to identify patterns, predict outcomes, and generate insights that aid in the identification and development of poten
Read more